# PPARγ Agonist Treatment for Cocaine Dependence

> **NCT02774343** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 30 (actual)

## Conditions studied

- Cocaine Use Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo
- **BEHAVIORAL:** Therapy
- **BEHAVIORAL:** Contingency Management

## Key facts

- **NCT ID:** NCT02774343
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774343, "PPARγ Agonist Treatment for Cocaine Dependence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02774343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*